Ticker Details
Codexis, Inc. Codexis Inc is a biotech company. It develops proprietary biocatalysts-enzymes or microbes that initiate or accelerate chemical reactions. It offers its products to the pharmaceutical industry. The company also develops advanced biofuels.
IPO Date:	April 22, 2010
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$226.33M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.22 | 2.85%
Avg Daily Range (30 D):	$0.10 | 3.94%
Avg Daily Range (90 D):	$0.08 | 4.43%

Institutional Daily Volume
Avg Daily Volume:	.38M
Avg Daily Volume (30 D):	1.1M
Avg Daily Volume (90 D):	1.85M

Trade Size
Avg Trade Size (Sh.):	121
Avg Trade Size (Sh.) (30 D):	142
Avg Trade Size (Sh.) (90 D):	206

Institutional Trades
Total Institutional Trades:	1,262
Avg Institutional Trade:	$1.45M
Avg Institutional Trade (30 D):	$.78M
Avg Institutional Trade (90 D):	$.72M
Avg Institutional Trade Volume:	.12M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.28M
Avg Closing Trade (30 D):	$.78M
Avg Closing Trade (90 D):	$.72M
Avg Closing Volume:	94.15K

News

Aug 28, 2025 @ 1:00 PM Codexis to Participate in Cantor Global Healthcare... Source: Georgia Erbez

May 22, 2025 @ 11:00 AM Codexis’ Landmark Presentations at TIDES US... Source: N/A

Apr 9, 2025 @ 9:00 PM Codexis Announces Byron Dorgan to Retire from Boar... Source: N/A

Feb 20, 2025 @ 3:00 PM Specialty Enzymes Market to Expand at 7.5% CAGR, R... Source: Sns Insider

Dec 4, 2024 @ 6:00 PM Global Artificial Sweeteners Market to Observe Gro... Source: Delveinsight

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.35	$-.1	$.12
Diluted EPS	$-.35	$-.1	$.12
Revenue	$78.09M	$15.25M	$38.92M
Gross Profit	$69.42M	$13.18M	$36.87M
Net Income / Loss	$-31.99M	$-8.7M	$9.6M
Operating Income / Loss	$-29.3M	$-8.04M	$10.56M
Cost of Revenue	$8.67M	$2.06M	$2.04M
Net Cash Flow	$18.72M	$-14.28M	$25.99M
PE Ratio